![]() ![]() The combined strength of Kite and Gilead allows us to remain innovative, agile, and ambitious in our mission to keep improving the lives of people with all types of cancer.įor more on Kite’s acquisition by Gilead Sciences in 2017, read the press release. Kite Pharmas ASCO ads aim to prep docs on CAR-T ahead of FDA approval. For Current Kite Pharma Employees and Contractors:Please log onto your Internal Career Site toSee this and similar jobs on LinkedIn. Confirmed: Gilead to acquire Kite Pharma for 11.9bn. As a vital part of Gilead - a founding member of the Foundation for the NIH’s Partnership for Accelerating Cancer Therapies - we are devoted to advancing the understanding of cell therapy as a transformational treatment option for cancer. Kite Pharma, and Dendreon Pharmaceuticals. ![]() ![]() The average Kite Pharma hourly pay ranges from approximately 25 per hour for a Manufacturing Associate to 67 per hour for a Project Manager. Since our acquisition by biopharma leader Gilead Sciences in October 2017, our combined strength has accelerated the advancement of our pipeline, including the launch of YESCARTA® (axicabtagene ciloleucel) and TECARTUS® (brexucabtagene autoleucel), and has expanded the impact of our strategic partnerships.Īs an independent operating company since 2019, we prioritize innovative R&D with the full resources, capabilities, and trust of Gilead. Manufacturing and Office Facility El Segundo, CA Kite Pharma is a leader in engineered T-cell therapy, transforming cancer treatment by developing innovative products that harness a patient’s own immune system to target and attack cancer cells. Kite Pharma El Segundo, CA 4.0 82 Recommend to a Friend Warner Biddle 0 Rating View open jobs at this location Kite Pharma El Segundo, CA Reviews 5.0 Current Employee 'Good pay' Distribution Specialist in El Segundo, CA Pros Great opportunity for advancement in other departments. The average Kite Pharma salary ranges from approximately 53,067 per year for a Manufacturing Associate to 444,819 per year for a Senior Director. Our Story A Singular Focus on Cell Therapyįounded in 2009 as a pioneer in cell therapy research, Kite’s leadership position in the immuno-oncology space was solidified with our research and development agreement with the National Cancer Institute in 2012 and when our commercial manufacturing site opened in El Segundo in 2016. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |